Willis Towers Watson Public Lim

Valuation Analysis

About the Company

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. The company operates through two segments: Health, Wealth & Career and Risk & Broking. It offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit programs, including medical, dental, disability, life, voluntary benefits, and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services. The company also

Willis Towers Watson Public Lim Stock at a Glance

Willis Towers Watson Public Lim (WTW) is currently trading at $262.63 with a market capitalization of $24.8B. The trailing P/E ratio stands at 15.41x, with a forward P/E of 11.84x. The 52-week range spans from $240.61 to $352.79; the current price is 25.6% below the yearly high. Year-over-year revenue growth stands at +8.5%. The net profit margin stands at 16.84%.

💰 Dividend

Willis Towers Watson Public Lim pays an annual dividend of $3.84 per share, representing a yield of 1.46%. The payout ratio stands at 21.84%.

📊 Analyst Rating

19 analysts rate Willis Towers Watson Public Lim (WTW) on consensus: Buy. The average price target is $331.68, implying +26.29% from the current price. Analyst price targets range from $275.00 to $391.00.

Willis Towers Watson Public Lim: The Investment Case in Detail

Willis Towers Watson Public Lim (WTW) operates in the Financial Services — specifically Insurance Brokers — and is headquartered in United Kingdom. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Earnings growth of 33% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. The combination of a 42.41% gross margin and 20.52% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Free cash flow is positive and net margins stand at 16.84%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

Valuation in Context

The PEG ratio at 1.27 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

What to Watch Next

• The forward P/E of 11.84x is meaningfully below the trailing 15.41x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 26.29% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Willis Towers Watson Public Lim?

Compare top-rated brokers — low fees, trusted providers, fully regulated.